Limitations, agreements, and source contact

Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). · Source last updated 2019-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

OTHER

restrictive Agreement

true

point Of Contact

email

nc@lipocine.com

organization

Lipocine, INC.

phone

8018819495

title

Nachiappan Chidambaram, Vice President, Product Development

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice